$0.02
−41.46%Oct 19, 2026, 12:45 UTC
OneMedNet Corp signed its 12th channel partner agreement with an unnamed global pharmaceutical intelligence and data solutions provider to distribute OneMedNet’s U.S.-sourced, de-identified clinical data to pharmaceutical customers worldwide.
Source:Oct 15, 2026, 12:45 UTC
OneMedNet announced a partnership adding a leading hospital system to its iRWD platform and federated provider network, with expansion of up to 12 additional hospitals expected.
Source:Oct 7, 2026, 12:30 UTC
OneMedNet announced a channel partner agreement with C&R Research, Inc., appointing it as distributor of OneMedNet’s U.S.-sourced real-world data in Korea and extending its commercial reach into the Asia Pacific region.
Source:Sep 30, 2026, 12:55 UTC
OneMedNet Corporation signed a seven-figure multiyear agreement to supply de-identified, multimodal, longitudinal clinical Real World Data to a commercially scaled AI-enabled precision medicine company.
Source:Sep 25, 2026, 15:50 UTC
OneMedNet Corporation announced a 1-for-10 reverse stock split of its issued and outstanding common shares, effective at 12:01 a.m. on a date to be set.
Source:Sep 23, 2026, 21:03 UTC
OneMedNet Corp elected Dr. Kenneth Alleyne, Sherry Coonse McCraw, and Dr. Jeffrey Yu as Class III directors effective September 18, 2026.
Sep 22, 2026, 12:40 UTC
OneMedNet Corporation entered a multi-year resale agreement with Atropos Health to expand commercial reach for its AI-driven real-world data offerings.
Source:Sep 18, 2026, 12:35 UTC
OneMedNet Corporation announced year-to-date bookings of approximately $16.2 million, a 16-fold increase versus the same period in 2025.
Source:Aug 31, 2026, 12:35 UTC
OneMedNet Corporation announced a new agreement to deliver de-identified clinical Real-World Data to a leading AI-driven drug development company, with the iRWD platform enabling feasibility, validation, and contract signing within three weeks of initial contact.
Source:Aug 17, 2026, 13:10 UTC
OneMedNet reported its quarterly results for the period ended June 30, 2026, disclosing zero Bitcoin holdings, $358,000 in cash, $4.73 million in current liabilities, and a going-concern warning about insufficient liquidity for the next 12 months.
Source:Jul 28, 2026, 12:30 UTC
OneMedNet entered into an agreement to supply regulatory-grade real-world data for foundational AI model development.
Source: